The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: The St. Jude children's research hospital experience

Cancer

Volumn 104, Issue 12, 2005, Pages 2837-2846

  McGregor, Lisa M ^a,b   Rao, Bhaskar N ^a,b   Davidoff, Andrew M ^a   Billups, Catherine A ^a   Hongeng, Suradej ^a,b,d   Santana, Victor M ^a,b   Hill, D Ashley ^a,c   Fuller, Christine ^a   Furman, Wayne L ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Disease free survival; Neuroblastoma; Postoperative complications; Surgical procedures; Survival

Indexed keywords

ALPHA INTERFERON; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; TENIPOSIDE; TOPOTECAN; LACTATE DEHYDROGENASE;

ADOLESCENT; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DRUG MEGADOSE; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MYCN GENE; NEUROBLASTOMA; ONCOGENE; ONSET AGE; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; ARTICLE; BRAIN SURGERY; CANCER LOCALIZATION; CHILD; CHILD CARE; CHILDHOOD CANCER; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; EARLY INTERVENTION; EVENT FREE SURVIVAL; GENE; INDUCTION CHEMOTHERAPY; LACTATE DEHYDROGENASE BLOOD LEVEL; NEPHRECTOMY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; AGE FACTORS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEUROBLASTOMA; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 29144520567     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21566     Document Type: Review

References (56)

1. Bowman LC, Castleberry RP, Cantor A, et al. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study. J Natl Cancer Inst. 1997;89:373-380.
2. DeCou JM, Bowman LC, Rao BN, et al. Infants with metastatic neuroblastoma have improved survival with resection of the primary tumor. J Pediatr Surg. 1995;30:937-940.
3. Bowman LC, Hancock ML, Santana VM, et al. Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988. J Clin Oncol. 1991;9:1599-1608.
4. Nitschke R, Smith EI, Shochat S, et al. Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. J Clin Oncol. 1988;6:1271-1279.
5. Azizkhan RG, Haase GM. Current biologic and therapeutic implications in the surgery of neuroblastoma. Semin Surg Oncol. 1993;9:493-501.
6. Chamberlain RS, Quinones R, Dinndorf P, Movassaghi N, Goodstein M, Newman K. Complete surgical resection combined with aggressive adjuvant chemotherapy and bone marrow transplantation prolongs survival in children with advanced neuroblastoma. Ann Surg Oncol. 1995;2:93-100.
7. Kaneko M, Ohakawa H, Iwakawa M. Is extensive surgery required for treatment of advanced neuroblastoma? J Pediatr Surg. 1997;32:1616-1619.
8. Berthold F, Trechow R, Utsch S, Zieschang J. Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol. 1992;14:207-215.
9. Castel V, Tovar JA, Costa E, et al. The role of surgery in stage IV neuroblastoma. J Pediatr Surg. 2002;37:1574-1578.
10. Castel V, Canete A, Navarro S, et al. Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results. Med Pediatr Oncol. 2001;37:537-542.
11. Kaneko M, Tsuchida Y, Uchino J, et al. Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma. J Pediatr Hematol Oncol. 1999;21:190-197.
12. Kawa K, Ohnuma N, Kaneko M, et al. Long-term survivors of advanced neuroblastoma with MYCN amplification: A report of 19 patients surviving disease-free for more than 66 months. J Clin Oncol. 1999;17:3216-3220.
13. Koop CE, Schnaufer L. The management of abdominal neuroblastoma. Cancer. 1975;35:905-909.
14. Powis MR, Imeson JD, Holmes SJ. The effect of complete excision on stage III neuroblastoma: a report of the European Neuroblastoma Study Group. J Pediatr Surg. 1996;31:516-519.
15. Strother D, van Hoff J, Rao PV, et al. Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group. Eur J Cancer. 1997;33:2121-2125.
16. von Schweinitz D, Hero B, Berthold F. The impact of surgical radicality on outcome in childhood neuroblastoma. Eur J Pediatr Surg. 2002;12:402-409.
17. La Quaglia MP, Kushner BH, Su W, et al. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg. 2004;39:412-417.
18. Azizkhan RG, Shaw A, Chandler JG. Surgical complications of neuroblastoma resection. Surgery. 1985;97:514-517.
19. Cecchetto G, Luzzatto C, Carli M, Guglielmi M, Zanesco L. The role of surgery in non-localized neuroblastoma. Analysis of 59 cases. Tumori. 1983;69:327-329.
20. Haase GM, Atkinson JB, Stram DO, Lukens JN, Matthay KK. Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems. J Pediatr Surg. 1995;30:289-294.
21. Haase GM, O'Leary MC, Ramsay NK, et al. Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg. 1991;26:1119-1123.
22. Haase GM, Wong KY, deLorimier AA, Sather HN, Hammond GD. Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg. 1989;24:194-200.
23. Kiely EM. The surgical challenge of neuroblastoma. J Pediatr Surg. 1994;29:128-133.
24. Kiely EM. Radical surgery for abdominal neuroblastoma. Semin Surg Oncol. 1993;9:489-492.
25. Koop CE. The role of surgery in resectable, nonresectable, and metastatic neuroblastoma. JAMA. 1968;205:157-158.
26. Kushner BH, Cheung NK, LaQuaglia MP, et al. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol. 1996;14:373-381.
27. La Quaglia MP, Kushner BH, Heller G, Bonilla MA, Lindsley KL, Cheung NK. Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg. 1994;29:1162-1165.
28. Le Tourneau JN, Bernard JL, Hendren WH, Carcassonne M. Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg. 1985;20:244-249.
29. Losty P, Quinn F, Breatnach F, O'Meara A, Fitzgerald RJ. Neuroblastoma-a surgical perspective. Eur J Surg Oncol. 1993;19:33-36.
30. Matsumura M, Atkinson JB, Hays DM, et al. An evaluation of the role of surgery in metastatic neuroblastoma. J Pediatr Surg. 1988;23:448-453.
31. O'Neill JA, Littman P, Blitzer P, Soper K, Chatten J, Shimada H. The role of surgery in localized neuroblastoma. J Pediatr Surg. 1985;20:708-712.
32. Shamberger RC, Allarde-Segundo A, Kozakewich HP, Grier HE. Surgical management of stage III and IV neuroblastoma: resection before or after chemotherapy? J Pediatr Surg. 1991;26:1113-1117.
33. Shorter NA, Davidoff AM, Evans AE, Ross AJ, III, Zeigler MM, O'Neill JA Jr. The role of surgery in the management of stage IV neuroblastoma: a single institution study. Med Pediatr Oncol. 1995;24:287-291.
34. Sitarz A, Finklestein J, Grosfeld J, et al. An evaluation of the role of surgery in disseminated neuroblastoma: a report from the Children's Cancer Study Group. J Pediatr Surg. 1983;18:147-151.
35. Tsuchida Y, Yokoyama J, Kaneko M, et al. Therapeutic significance of surgery in advanced neuroblastoma: a report from the study group of Japan. J Pediatr Surg. 1992;27:616-622.
36. Yokoyama J, Ikawa H, Endow M, et al. The role of surgery in advanced neuroblastoma. Eur J Pediatr Surg. 1995;5:23-26.
37. Yokoyama S, Hirakawa H, Soeda J, et al. The strategy to treat disseminated neuroblastoma utilizing bone marrow transplantation: what is the surgeon's role? Surg Today. 1994;24:895-899.
38. Brodeur GM, Seeger RC, Barrett A, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol. 1988;6:1874-1881.
39. Adams GA, Shochat SJ, Smith EI, et al. Thoracic neuroblastoma: a Pediatric Oncology Group study. J Pediatr Surg. 1993;28:372-377.
40. Haberle B, Hero B, Berthold F, von Schweinitz D. Characteristics and outcome of thoracic neuroblastoma. Eur J Pediatr Surg. 2002;12:145-150.
41. Haase GM, O'Leary MC, Stram DO, et al. Pelvic neuroblastoma-implications for a new favorable subgroup: a Children's Cancer Group experience. Ann Surg Oncol. 1995;2:516-523.
42. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466-1477.
43. Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer. 1999;86:364-372.
44. Alvarado CS, London WB, Look AT, et al. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study. J Pediatr Hematol Oncol. 2000;22:197-205.
45. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984;224:1121-1124.
46. Shapiro DN, Valentine MB, Rowe ST, et al. Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma. Am J Pathol 1993;142:1339-1346.
47. Davidoff AM, Corey BL, Hoffer FA, Santana VM, Furman WL, Shochat SJ. Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy. Pediatr Blood Cancer. 2005;44:158-162.
48. Fuller CE, Schmidt RE, Roth KA, et al. Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features. J Neuropathol Exp Neurol. 2003;62:1118-1128.
49. Kaplan EL, Meier P. Nonparametric-estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
50. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. 2. Analysis and examples. Br J Cancer. 1977;35:1-39.
51. Kuroda T, Saeki M, Honna T, Masaki H, Tsunematsu Y. Clinical significance of intensive surgery with intraoperative radiation for advanced neuroblastoma: does it really make sense? J Pediatr Surg. 2003;38:1735-1738.
52. Adkins ES, Sawin R, Gerbing RB, London WB, Matthay KK, Haase GM. Efficacy of complete resection for high-risk neuroblastoma: A Children's Cancer Group study. J Pediatr Surg. 2004;39:931-936.
53. Matthay KK, Atkinson JB, Stram DO, Selch M, Reynolds CP, Seeger RC. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Children's Cancer Group pilot study. J Clin Oncol. 1993;11:2226-2233.
54. Goldie JH, Coldman AJ, Gudauskas GA. Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep. 1982;66:439-449.
55. Goldie JH, Goldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep. 1979;63:1727-1733.
56. Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345:1655-1659.